Increases in Serial Pretreatment 18F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy

Por Nicolas D. Prionas, MD, PhD, Rie von Eyben, MSc, Esther Yi, BA, Sonya Aggarwal, BA, Jenny Shaffer, MD, Jose Bazan, MD, David Eastham, MD, Peter G. Maxim, PhD, Edward E. Graves, PhD, Maximilian Diehn, MD, PhD, Michael F. Gensheimer, MD, Billy W. Loo, Jr., MD, PhD
Publicado em 2019-04-01